Healthcare Pharmaceutical Biotech

Medical Care Technologies Inc. (OTC PINK:MDCE) Reaches #2 on InvestorsHub Breakout Board as Investor Attention Accelerates Following Strategic Updates

April 30, 2026 11:45 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("the Company") today announced it has reached #2 on the InvestorsHub breakout board, reflecting a surge in investor attention following the Company's recent strategic updates. The increased visibility highlights growing market awareness as investors evaluate MDCE's expanding position across artificial intelligence, healthcare applications, and commercial technology platforms. Through its...

Read more

Smart Arches Launches "Angel Arches: Teacher Appreciation Edition," Offering Free Life-Changing Dental Implant Treatment to a Deserving Educator

April 30, 2026 10:50 AM

Smart Arches Dental Implants, a leading dental implant provider with six locations across Pennsylvania, New Jersey, and Maryland, is awarding one teacher in the region a complete dental implant procedure valued at up to $45,000, entirely at no cost. The program, called Angel Arches: Teacher Appreciation Edition, is now accepting applications from educators who have suffered from severe dental disease, tooth loss, or implant-level need and could...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Launches Updated Corporate Website, Expands Transparency Initiatives, and Highlights Strategic Roadmap

April 30, 2026 9:30 AM

Medical Care Technologies Inc. (OTCID:MDCE) ("the Company") today announced the launch of its newly redesigned corporate website, now live at https://medicalcaretechnologies.com, providing investors and stakeholders with expanded visibility into the Company's strategic roadmap, operational priorities, and long-term growth initiatives. The updated platform introduces a modern, intuitive user experience while emphasizing transparency through a...

Read more

The Preventative Care Crisis: HealthJoy's Predictive Analytics Report Reveals Only 17% of Employees Plan to Complete Annual Physical Despite Rising Chronic and Complex Health Needs

April 30, 2026 9:00 AM

HealthJoy, the Benefits Operating System for self-insured employers nationwide, today released its fourth annual Member Health Goals Report predicting upcoming trends in workforce health ahead of a daunting 2027 renewal season. Findings reveal a notable decline in employees pursuing preventive care, with only 17% of respondents planning to complete their annual physical in 2026. This decline comes despite a rise in chronic health conditions,...

Read more

Genflow Biosciences PLC Announces Final Results

April 30, 2026 9:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases, is pleased to announce its final results for the year ended 31 December 2025. The Annual Report will be available to view on the Company's website at www.genflowbio.com and the full, unedited text of its final results can be...

Read more

Teva's 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets

April 30, 2026 9:00 AM

Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today published its 2025 Healthy Future Report, outlining performance against its sustainability targets, which are focused on the issues most relevant to its business, patients and the planet. Teva surpassed all 2025 targets associated with its sustainability-linked bonds-totaling approximately $7.5 billion across its 2021 and 2023 issuances. These commitments reflect progress in areas...

Read more

AGS Health(R) Recognized as a Leader in RCM Intelligent Operations by Everest Group

April 30, 2026 9:00 AM

AGS Health®, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., has been named a Leader in Revenue Cycle Management (RCM) Intelligent Operations PEAK Matrix® Assessment 2026 by Everest Group. The RCM Intelligent Operations PEAK Matrix® Assessment evaluated 34 RCM operations service providers on their market impact and ability to deliver services...

Read more

CVS Health's Annual Impact in Arizona

April 30, 2026 9:00 AM

Originally published in the CVS Health National Economic Impact Report With more than 9,000 locations and 300,000 employees, CVS Health is a driving force in the American economy, delivering $474 billion in economic impact nationwide. As one of the country's largest private employers, we're making health care more affordable and accessible for you and your family. Discover how our economic footprint benefits communities across the U.S: creating...

Read more

Greatly Health Raises $4M to Expand Access to Evidence-Based Integrative Cancer Care

April 30, 2026 8:00 AM

Greatly Health, a healthtech company delivering integrative oncology at scale, today announced it has raised a $4 million seed round co-led by Pear VC and Commonweal Ventures, with participation from Flare Capital Partners and strategic investors. The company is building a new category of cancer care by integrating evidence-based supportive therapies, such as exercise, nutrition, and mind-body interventions, directly into the treatment journey....

Read more

Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer

April 30, 2026 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a clinical-stage biotechnology company developing small-molecule therapeutics targeting epigenetic and metabolic drivers of cancer and age-related disease, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its lead candidate, Telomir-Zn, for the treatment of patients with advanced or...

Read more

Change in Number of Shares and Votes in Ascelia Pharma AB

April 30, 2026 7:20 AM

Ascelia Pharma (STO:ACE): During April, the registered number of shares and votes in Ascelia Pharma AB ("Ascelia Pharma") has increased due to the directed new issue of ordinary shares which was announced by Ascelia Pharma on 23 April 2026. As of 30 April 2026, the total number of shares in Ascelia Pharma amounts to 134,569,246 shares, whereof 133,535,460 are ordinary shares with one vote each and 1,033,786 are series C shares with 1/10 vote...

Read more

Adjusted Timeline for the Previously Communicated Rights Issue

April 30, 2026 6:30 AM

AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, announces that the timeline for the previously communicated rights issue of approximately SEK 30.1 million is being adjusted due to technical issuance reasons. All terms of the Rights Issue, including the subscription price of SEK...

Read more

Wall Pilates Emerges as a Leading Home Workout Trend in the Digital Wellness Boom

April 30, 2026 6:20 AM

Wall Pilates, As the global wellness industry continues to expand, consumers are increasingly prioritizing convenient and adaptable fitness solutions that can be performed from home. Among the trends gaining traction is wall-based Pilates, a variation of traditional Pilates exercises that utilizes a wall for support, stability, and resistance. This approach to fitness is attracting attention from both beginners and experienced practitioners...

Read more

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026

April 30, 2026 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the Company will release results for its first quarter of 2026, ended March 31, 2026, after the market closes on Thursday, May 7, 2026, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time. To access the conference call, dial toll-free 877-407-0989, for international calls, dial 201-389-0921, ten minutes before the conference. The call can...

Read more

Evotec Receives Grants to Advance Tuberculosis Treatment

April 30, 2026 3:20 AM

Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced that it has received two grants from the Gates Foundation for drug discovery and translation in tuberculosis (TB), following four earlier TB grants from the foundation, amounting to $4.9 million over 25 months and $5 million over 24 months. The new funding underscores Evotec's commitment to translating innovative science into impactful therapies addressing high-priority public...

Read more

IRLAB: Invitation to the Interim Report for Q1 2026 Presentation and Webcast

April 30, 2026 3:15 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will hold a presentation in conjunction with the publication of the interim report for the period January - March 2026. The interim report will be published on Wednesday, May 6, 2026, at 07:00 CEST. The presentation will be held on May 6,...

Read more

Theralogix Introduces AndroSyn: An Evidence-Based Supplement Formulated to Improve Testosterone Levels*

April 30, 2026 12:00 AM

Theralogix, a trusted leader in nutritional supplements, is proud to announce the launch of AndroSyn™, a scientifically formulated supplement designed to support healthy testosterone levels and promote overall men's health and vitality.* Testosterone plays a crucial role in men's health, influencing muscle strength, energy levels, mood, mental clarity, and overall physical performance.* As men age, maintaining healthy testosterone levels becomes...

Read more

CMS Is Quietly Pushing Unvalidated Hemp -Marijuana Products on America's Elderly - and Calling It Healthcare

April 29, 2026 11:42 PM

Somewhere in America right now, a Medicare patient over 65 - perhaps managing cancer, perhaps on blood thinners, perhaps already navigating a complex medication regimen - may be offered a hemp-derived cannabinoid product through their federally sponsored health program. Not because a doctor prescribed it after a clinical evaluation. Not because the FDA approved it. Not because a single randomized controlled trial has demonstrated it is safe or...

Read more

Healthcare Innovator and Strategist Executes Multimillion-Dollar Acquisition of Pediatric Asset

April 29, 2026 11:10 PM

Rajesh Nandipaty, a Master of Healthcare Innovation (MHI) graduate, successfully facilitated the multimillion-dollar acquisition and strategic transition of a landmark pediatric clinic in Weslaco, Texas. The transaction, finalized in January 2025, marks a sophisticated exit for the founding pediatrician and secures the facility's role as a cornerstone of regional specialized care. The acquisition centered on a high-spec commercial facility...

Read more

Maximus Labs Gummies Reviewed: Don't Buy MaximusLabs Gummies for Men Before Reading This Latest Report First!

April 29, 2026 6:45 PM

Disclaimers: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This content is for informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before starting any new supplement. Maximus Labs Male Gummies: Ingredient Overview, Pricing Structure, and Rising Consumer Search Trends If you searched for...

Read more